This federal contract award, with an ID of SPE2DB22D2206|SPE2DB25FDW89, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,566,177,414 units of the drug Celecoxib 200 mg capsules, with a completion date of October 23, 2024 and a ceiling value of $2,886.07.
The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. The contract award does not have a set-aside designation, indicating open competition.
Generated 1/22/25, 12:56 AM